PWAM
PBYI icon

Private Wealth Asset Management’s Puma Biotechnology PBYI Stock Holding History

Private Wealth Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.4K Hold
3,500
– – ﹤0.01% 545
2025
Q4 		$20.8K Hold
3,500
– – ﹤0.01% 547
2025
Q3 		$18.6K Hold
3,500
– – ﹤0.01% 538
2025
Q2 		$12K Buy
3,500
+1,500
+75% +$4.79K ﹤0.01% 630
2025
Q1 		$5.92K Buy
+2,000
New +$6.26K ﹤0.01% 714

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Private Wealth Asset Management's PBYI Position: Q1 2026 in Review

Private Wealth Asset Management held its Puma Biotechnology (PBYI) position steady in Q1 2026 at 3,500 shares worth $22.4K. The position accounts for ﹤0.01% of the portfolio, ranked #545.

Private Wealth Asset Management first reported a position in PBYI in Q1 2025 and has held it in 5 quarters since. 157 funds tracked by Wall St. Rank hold PBYI as of Q1 2026.

  • Private Wealth Asset Management held 3,500 shares of Puma Biotechnology worth $22.4K as of Q1 2026.
  • Private Wealth Asset Management left its Puma Biotechnology share count unchanged in Q1 2026.
  • Puma Biotechnology made up ﹤0.01% of Private Wealth Asset Management's portfolio in Q1 2026, its #545 holding.
  • Private Wealth Asset Management first reported a position in Puma Biotechnology in Q1 2025 and has held it in 5 quarters since.
  • 157 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2026.

Based on Private Wealth Asset Management's 13F filing for Q1 2026, filed 6 May 2026.